- Filed
- Sep 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Sep 22, 2025 | 590.36M sh |
| Shares Diluted | Q2 2025 · Aug 31, 2025 | 597.37M sh |
| Shares Diluted | Q2 2025 · Aug 31, 2025 | 598.7M sh |
| Shares Diluted | Q2 2025 · Aug 31, 2024 | 591.61M sh |
| Shares Diluted | Q2 2025 · Aug 31, 2024 | 590.19M sh |
| Stock Repurchased | Q2 2025 · Aug 31, 2025 | $20M |
| Stock Repurchased | Q2 2025 · Aug 31, 2025 | $30M |
| Stock Repurchased | Q2 2025 · Aug 31, 2024 | $0 |
| Capex | Q2 2025 · Aug 31, 2025 | $1.7M |
| Capex restated | Q2 2025 · Aug 31, 2024 | $1.9M |
| Operating Cash Flow | Q2 2025 · Aug 31, 2025 | −$14.1M |
| Operating Cash Flow restated | Q2 2025 · Aug 31, 2024 | −$31.1M |
| Long Term Debt | Q2 2025 · Aug 31, 2025 | $195.9M |
| Long Term Debt | Q2 2025 · Feb 28, 2025 | $195.3M |
| Short Term Investments | Q2 2025 · Aug 31, 2025 | $14.1M |
| Short Term Investments | Q2 2025 · Feb 28, 2025 | $71.1M |
| Cash And Equivalents | Q2 2025 · Aug 31, 2025 | $276.4M |
| Cash And Equivalents | Q2 2025 · Feb 28, 2025 | $266.7M |
| Stockholders Equity | Q2 2025 · Aug 31, 2025 | $725.1M |
| Stockholders Equity | Q2 2025 · May 31, 2025 | $725.1M |
| Stockholders Equity | Q2 2025 · Feb 28, 2025 | $719.9M |
| Stockholders Equity restated | Q2 2025 · Aug 31, 2024 | $732.1M |
| Stockholders Equity restated | Q2 2025 · May 31, 2024 | $742.6M |
| Stockholders Equity restated | Q2 2025 · Feb 29, 2024 | $775.1M |
| Current Liabilities | Q2 2025 · Aug 31, 2025 | $230.2M |
| Current Liabilities | Q2 2025 · Feb 28, 2025 | $344.3M |
| Total Liabilities | Q2 2025 · Aug 31, 2025 | $459M |
| Total Liabilities | Q2 2025 · Feb 28, 2025 | $575.7M |
| Current Assets | Q2 2025 · Aug 31, 2025 | $507.2M |
| Current Assets | Q2 2025 · Feb 28, 2025 | $591.5M |
| Total Assets | Q2 2025 · Aug 31, 2025 | $1.18B |
| Total Assets | Q2 2025 · Feb 28, 2025 | $1.3B |
| Eps Diluted | Q2 2025 · Aug 31, 2025 | $0.02 |
| Eps Diluted | Q2 2025 · Aug 31, 2025 | $0.03 |
| Eps Diluted | Q2 2025 · Aug 31, 2024 | −$0.03 |
| Eps Diluted | Q2 2025 · Aug 31, 2024 | −$0.10 |
| Eps Basic | Q2 2025 · Aug 31, 2025 | $0.02 |
| Eps Basic | Q2 2025 · Aug 31, 2025 | $0.03 |
| Eps Basic | Q2 2025 · Aug 31, 2024 | −$0.03 |
| Eps Basic | Q2 2025 · Aug 31, 2024 | −$0.10 |
| Rd Expense | Q2 2025 · Aug 31, 2025 | $25.6M |
| Rd Expense | Q2 2025 · Aug 31, 2025 | $50.6M |
| Rd Expense restated | Q2 2025 · Aug 31, 2024 | $27.1M |
| Rd Expense restated | Q2 2025 · Aug 31, 2024 | $57.7M |
| Net Income | Q2 2025 · Aug 31, 2025 | $13.3M |
| Net Income | Q2 2025 · Aug 31, 2025 | $15.2M |
| Net Income restated | Q2 2025 · Aug 31, 2024 | −$19.7M |
| Net Income restated | Q2 2025 · Aug 31, 2024 | −$61.1M |
| Operating Income | Q2 2025 · Aug 31, 2025 | $11.5M |
| Operating Income | Q2 2025 · Aug 31, 2025 | $13.5M |
| Operating Income restated | Q2 2025 · Aug 31, 2024 | $2.2M |
| Operating Income restated | Q2 2025 · Aug 31, 2024 | −$10.7M |
| Gross Profit | Q2 2025 · Aug 31, 2025 | $96.6M |
| Gross Profit | Q2 2025 · Aug 31, 2025 | $186.9M |
| Gross Profit restated | Q2 2025 · Aug 31, 2024 | $88.6M |
| Gross Profit restated | Q2 2025 · Aug 31, 2024 | $178.6M |
| Cost Of Revenue | Q2 2025 · Aug 31, 2025 | $33M |
| Cost Of Revenue | Q2 2025 · Aug 31, 2025 | $64.4M |
| Cost Of Revenue restated | Q2 2025 · Aug 31, 2024 | $37.6M |
| Cost Of Revenue restated | Q2 2025 · Aug 31, 2024 | $71M |
| Revenue | Q2 2025 · Aug 31, 2025 | $129.6M |
| Revenue | Q2 2025 · Aug 31, 2025 | $251.3M |
| Revenue restated | Q2 2025 · Aug 31, 2024 | $126.2M |
| Revenue restated | Q2 2025 · Aug 31, 2024 | $249.6M |